Compared with control subjects, although there was no obvious change in serum glucose levels, serum insulin levels and HOMA-IR values were significantly increased in patients with NAFLD (Figure 7a–c), suggesting the presence of IR in the patients with NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.